Qingdao Haier Valuation

688139 Stock   35.20  0.00  0.00%   
At this time, the company appears to be overvalued. Qingdao Haier Biomedical holds a recent Real Value of USD28.83 per share. The prevailing price of the company is USD35.2. Our model determines the value of Qingdao Haier Biomedical from analyzing the company fundamentals such as Return On Equity of 0.0816, operating margin of 0.14 %, and Shares Outstanding of 317.95 M as well as examining its technical indicators and probability of bankruptcy.
Price Book
2.6018
Enterprise Value
9.4 B
Enterprise Value Ebitda
24.1675
Price Sales
5.0041
Trailing PE
31.1504
Overvalued
Today
35.20
Please note that Qingdao Haier's price fluctuation is not too volatile at this time. Calculation of the real value of Qingdao Haier Biomedical is based on 3 months time horizon. Increasing Qingdao Haier's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Qingdao Haier is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Qingdao Stock. However, Qingdao Haier's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  35.2 Real  28.83 Hype  35.45 Naive  34.23
The real value of Qingdao Stock, also known as its intrinsic value, is the underlying worth of Qingdao Haier Biomedical Company, which is reflected in its stock price. It is based on Qingdao Haier's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Qingdao Haier's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
28.83
Real Value
38.72
Upside
Estimating the potential upside or downside of Qingdao Haier Biomedical helps investors to forecast how Qingdao stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Qingdao Haier more accurately as focusing exclusively on Qingdao Haier's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.340.420.53
Details
Hype
Prediction
LowEstimatedHigh
32.4335.4538.47
Details
Naive
Forecast
LowNext ValueHigh
31.2034.2337.25
Details

Qingdao Haier Cash

949.36 Million

Qingdao Haier Total Value Analysis

Qingdao Haier Biomedical is presently estimated to have takeover price of 9.39 B with market capitalization of 11.19 B, debt of 20.8 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Qingdao Haier fundamentals before making investing decisions based on enterprise value of the company

Qingdao Haier Investor Information

About 38.0% of the company shares are owned by insiders or employees . The book value of Qingdao Haier was presently reported as 13.74. The company last dividend was issued on the 6th of June 2024. Based on the analysis of Qingdao Haier's profitability, liquidity, and operating efficiency, Qingdao Haier Biomedical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.
Current ValueLast YearChange From Last Year 10 Year Trend
Total Cash From Operating Activities413.8 M286.7 M
Way Up
Slightly volatile
Operating Income306.7 M394.5 M
Significantly Down
Slightly volatile

Qingdao Haier Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Qingdao Haier has an asset utilization ratio of 41.28 percent. This suggests that the Company is making USD0.41 for each dollar of assets. An increasing asset utilization means that Qingdao Haier Biomedical is more efficient with each dollar of assets it utilizes for everyday operations.
 
Covid

Qingdao Haier Ownership Allocation

Qingdao Haier owns a total of 317.95 Million outstanding shares. Qingdao Haier has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.

Qingdao Haier Profitability Analysis

The company reported the revenue of 2.28 B. Net Income was 406.07 M with profit before overhead, payroll, taxes, and interest of 1.38 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Qingdao Haier's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Qingdao Haier and how it compares across the competition.

About Qingdao Haier Valuation

The stock valuation mechanism determines Qingdao Haier's current worth on a weekly basis. Our valuation model uses a comparative analysis of Qingdao Haier. We calculate exposure to Qingdao Haier's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Qingdao Haier's related companies.
Last ReportedProjected for Next Year
Gross Profit1.3 B806 M

Qingdao Haier Quarterly Retained Earnings

1.93 Billion

Complementary Tools for Qingdao Stock analysis

When running Qingdao Haier's price analysis, check to measure Qingdao Haier's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Qingdao Haier is operating at the current time. Most of Qingdao Haier's value examination focuses on studying past and present price action to predict the probability of Qingdao Haier's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Qingdao Haier's price. Additionally, you may evaluate how the addition of Qingdao Haier to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency